Gabriela Gruia - 05 May 2023 Form 3 Insider Report for Aprea Therapeutics, Inc. (APRE)

Role
Director
Signature
/s/ John P. Hamill, Attorney-in-fact
Issuer symbol
APRE
Transactions as of
05 May 2023
Net transactions value
$0
Form type
3
Filing time
08 May 2023, 17:16:11 UTC
Previous filing
06 Jun 2022
Next filing
15 Jun 2023

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney